Ensign Peak Advisors, Inc Zoetis Inc. Transaction History

Ensign Peak Advisors, Inc

$54.2 Billion
Q2 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 397,164 shares of ZTS stock, worth $71 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

397,164

Previous 432,352 8.14%

Holding current value

$71 Million

Previous $73.2 Million 5.89%

% of portfolio

0.13%

Previous 0.14%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$145.54 - $178.83 $5.12 Million - $6.29 Million	-35,188 Reduced 8.14%	397,164 $68.9 Million
Q1 2024 May 14, 2024	BUY	$165.67 - $199.94 $4.58 Million - $5.53 Million	27,672 Added 6.84%	432,352 $73.2 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $9.83 Million - $13 Million	64,929 Added 19.11%	404,680 $79.9 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $719,203 - $829,489	-4,303 Reduced 1.25%	339,751 $59.1 Million
Q2 2023 Aug 14, 2023	BUY	$160.94 - $186.23 $1.31 Million - $1.52 Million	8,154 Added 2.43%	344,054 $59.2 Million
Q1 2023 May 15, 2023	BUY	$145.48 - $175.02 $2.43 Million - $2.92 Million	16,688 Added 5.23%	335,900 $55.9 Million
Q4 2022 Feb 13, 2023	BUY	$131.14 - $157.47 $4.99 Million - $5.99 Million	38,041 Added 13.53%	319,212 $46.8 Million
Q3 2022 Nov 14, 2022	BUY	$148.29 - $182.55 $6.32 Million - $7.78 Million	42,644 Added 17.88%	281,171 $41.7 Million
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $2.54 Million - $3.26 Million	-16,278 Reduced 6.39%	238,527 $41 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $4.21 Million - $5.43 Million	-23,215 Reduced 8.35%	254,805 $48.1 Million
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $6.58 Million - $8.39 Million	33,950 Added 13.91%	278,020 $67.8 Million
Q3 2021 Nov 12, 2021	BUY	$189.29 - $209.69 $4.16 Million - $4.61 Million	21,963 Added 9.89%	244,070 $47.4 Million
Q2 2021 Aug 13, 2021	SELL	$155.9 - $187.99 $935,711 - $1.13 Million	-6,002 Reduced 2.63%	222,107 $41.4 Million
Q1 2021 May 12, 2021	BUY	$144.0 - $169.39 $8.51 Million - $10 Million	59,114 Added 34.98%	228,109 $35.9 Million
Q4 2020 Feb 12, 2021	SELL	$157.07 - $174.35 $23.3 Million - $25.8 Million	-148,220 Reduced 46.73%	168,995 $28 Million
Q3 2020 Nov 12, 2020	BUY	$137.1 - $165.37 $6.75 Million - $8.14 Million	49,242 Added 18.38%	317,215 $52.5 Million
Q2 2020 Aug 12, 2020	BUY	$111.92 - $142.53 $2.71 Million - $3.45 Million	24,210 Added 9.93%	267,973 $36.7 Million
Q1 2020 May 11, 2020	BUY	$92.66 - $144.94 $10.4 Million - $16.3 Million	112,191 Added 85.27%	243,763 $28.7 Million
Q4 2019 Feb 14, 2020	BUY	$116.25 - $133.25 $15.3 Million - $17.5 Million	131,572 New	131,572 $17.4 Million

Others Institutions Holding ZTS

# of Institutions

1,922

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Zoetis Inc. Transaction History